KRT8P10: A Potential Drug Target and Biomarker (G344320)

Target Name: KRT8P10

NCBI ID: G344320

KRT8P10

Other Name(s): keratin 8 pseudogene 10 | Keratin 8 pseudogene 10

KRT8P10: A Potential Drug Target and Biomarker

Keratin is a protein that plays a vital role in the structure and function of hair and nails. It is composed of several types of proteins, including keratin 8 (K8), which is a protein that is abundant in the hair and scalp. K8 is the precursor to the terminal sulfur protein, which is responsible for the brown color and strength of the hair.

Recent studies have identified KRT8P10, a pseudogene located on chromosome 10, as a potential drug target and biomarker for various diseases, including cancer. KRT8P10 is a gene that encodes a protein that is similar to K8, but with some differences in its sequence.

The KRT8P10 gene has been identified as a potential drug target because it is involved in the development and progression of various diseases, including cancer. For example, studies have shown that individuals with certain genetic variations in the KRT8P10 gene are at an increased risk of developing breast cancer. Additionally, KRT8P10 has been shown to be involved in the development of skin cancer, and may also be involved in the development of other cancers.

In addition to its potential as a drug target, KRT8P10 has also been identified as a potential biomarker for cancer. The KRT8P10 gene has been shown to be expressed in various tissues and cells, including cancer cells. Additionally, studies have shown that KRT8P10 can be used as a marker for cancer diagnosis and monitoring. For example, KRT8P10 has been shown to be expressed in the blood and lymphatic systems, which makes it a potential biomarker for cancer diagnosis and monitoring.

KRT8P10 has also been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and inflammation. For example, studies have shown that KRT8P10 is involved in the regulation of cell adhesion and migration, as well as in the regulation of the immune response.

In conclusion, KRT8P10 is a gene that has the potential to be a drug target and biomarker for various diseases, including cancer. Its involvement in the development and progression of these diseases, as well as its potential as a biomarker, make it an attractive target for further research and development.

Note: This article is not a real-world medical recommendation and should not be taken as such. It is intended for informational purposes only and should not be used as a substitute for professional medical advice.

Protein Name: Keratin 8 Pseudogene 10

The "KRT8P10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets